Srutarshi Ghosh
Research Subjects
Srutarshi Ghosh has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Anurug Biswas
Physical Medicine & Rehabilitation, All India Institute of Medical Sciences, Kalyani, Kalyani, West Bengal, India
2 shared publications - Jyoti Mbbs Pandey
From the Department of Physical Medicine and Rehabilitation, All India Institute of Medical Sciences, Patna, India
2 shared publications - Sanjay Kumar Pandey
Department of Physical Medicine and Rehabilitation, All India Institute of Medical Sciences, Patna, Bihar, India
2 shared publications - Amvrine Ganguly
Department of Psychiatry, Mayo Clinic College of Medicine and Science, Rochester, MN, USA
1 shared publication - Anil Kumar Gupta
Rush University Medical Center
1 shared publication Anjan Dasgupta
Department of Biochemistry, Ballygunj Science College, University of Calcutta, Kolkata 700019, India
1 shared publication
Latest Publications
- 15 December 2023
- Published by Elsevier in Journal of the Academy of Consultation-Liaison Psychiatry
- Vol. 64, S28
(056) Role of inpatient Rehabilitation in Managing Delirium: A Review
- 15 December 2023
- Published by Elsevier in Journal of the Academy of Consultation-Liaison Psychiatry
- Vol. 64, S28
(056) Role of inpatient Rehabilitation in Managing Delirium: A Review
- 21 August 2023
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 103 (3) , 188-193
Association of Sleep Quality With Fatigue in Post–COVID-19 Patients in an Indian Population
Objective: The aims of the study are to assess the quality of sleep in recently recovered COVID-19 and long-COVID cases and to determine its associations with fatigue and pain. Methods: Post–COVID-19 cases (n = 201) and controls (n = 206) were assessed using the Pittsburgh Sleep Quality Index questionnaire for sleep quality, Fatigue Severity Scale for fatigue, and Numeric Pain Rating Scale for pain in this observational study. Results: Global Pittsburgh Sleep Quality Index score was higher (P ≤ 0.001) among cases (5.7 ± 5.1; 95% confidence interval, 5.0–6.4) than controls (2.1 ± 2.0; 95% confidence interval, 1.8–2.4). Normal sleep latency was observed in 56 (27.9%) patients and 164 (79.6%) controls (P < 0.001). Fatigue Severity Scale score was higher (P ≤ 0.001) among cases (16.8 ± 10.2; 95% confidence interval, 15.4, 18.2) against controls (10.9 ± 4.1; 95% confidence interval, 10.3–11.4). The Fatigue Severity Scale scores in mild, moderate, and severe COVID-19 were 14.3 ± 8.1, 22.1 ± 10.8, and 22.8 ± 13, respectively (P < 0.001) and higher in the older (20.7 ± 12.1) and middle-aged (19.6 ± 10.3) than in younger (13.9 ± 8.3) (P ≤ 0.001) cases. The global Pittsburgh Sleep Quality Index score was positively correlated with the Fatigue Severity Scale (r = 0.755, P < 0.001) and Numeric Pain Rating Scale scores (r = 0.657, P < 0.001). Numeric Pain Rating Scale score correlated with Fatigue Severity Scale score (r = 0.710, P < 0.001). Fatigue Severity Scale and global Pittsburgh Sleep Quality Index scores were higher in the long-COVID group (P < 0.001). Conclusions: Significantly poor sleep quality was observed in post–COVID-19 individuals including long COVID being positively associated with fatigue and pain.
- 21 August 2023
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 103 (3) , 188-193
Association of Sleep Quality With Fatigue in Post–COVID-19 Patients in an Indian Population
Objective: The aims of the study are to assess the quality of sleep in recently recovered COVID-19 and long-COVID cases and to determine its associations with fatigue and pain. Methods: Post–COVID-19 cases (n = 201) and controls (n = 206) were assessed using the Pittsburgh Sleep Quality Index questionnaire for sleep quality, Fatigue Severity Scale for fatigue, and Numeric Pain Rating Scale for pain in this observational study. Results: Global Pittsburgh Sleep Quality Index score was higher (P ≤ 0.001) among cases (5.7 ± 5.1; 95% confidence interval, 5.0–6.4) than controls (2.1 ± 2.0; 95% confidence interval, 1.8–2.4). Normal sleep latency was observed in 56 (27.9%) patients and 164 (79.6%) controls (P < 0.001). Fatigue Severity Scale score was higher (P ≤ 0.001) among cases (16.8 ± 10.2; 95% confidence interval, 15.4, 18.2) against controls (10.9 ± 4.1; 95% confidence interval, 10.3–11.4). The Fatigue Severity Scale scores in mild, moderate, and severe COVID-19 were 14.3 ± 8.1, 22.1 ± 10.8, and 22.8 ± 13, respectively (P < 0.001) and higher in the older (20.7 ± 12.1) and middle-aged (19.6 ± 10.3) than in younger (13.9 ± 8.3) (P ≤ 0.001) cases. The global Pittsburgh Sleep Quality Index score was positively correlated with the Fatigue Severity Scale (r = 0.755, P < 0.001) and Numeric Pain Rating Scale scores (r = 0.657, P < 0.001). Numeric Pain Rating Scale score correlated with Fatigue Severity Scale score (r = 0.710, P < 0.001). Fatigue Severity Scale and global Pittsburgh Sleep Quality Index scores were higher in the long-COVID group (P < 0.001). Conclusions: Significantly poor sleep quality was observed in post–COVID-19 individuals including long COVID being positively associated with fatigue and pain.
- Open Access
- 1 March 2023
- Published by Scientific Scholar in International Journal of Recent Surgical and Medical Sciences
- Vol. 10, S101-S103
Uncommon Events of Fall and Mood Changes Observed in Post-COVID-19 Patients: A Case Series
Coronavirus disease 2019 (COVID-19) infection in some patients has been documented to cause acute central nervous system (CNS) affection, or CNS depression, even in the absence of demonstrable hypoxia. These observations indicate that there may be some direct effect of the virus on CNS. In this case series of cured post-COVID-19 cases, mood changes like elation, depression, and emotionally labile state have been reported in three previously healthy individuals. The mood changes are waning very slowly in them with the passage of time. All of them also sustained fall sometime following acute COVID-19. Fall is considered to be an event indicating frailty and old age, and there is no mood change associated with fall in that population. Here, the three cases are being reported because neither fall nor mood changes during post-COVID-19 phase have been reported as yet to the best of our knowledge. The case series is worth reporting to generate awareness about the matter in the scientific community and also to indicate that further research in this field is required either to accept or to reject any correlation between COVID-19 infection and fall or mood change in otherwise healthy individuals, which can even be due to some direct effect of the virus on CNS.
- 1 March 2023
- Published by Scientific Scholar in International Journal of Recent Surgical and Medical Sciences
- Vol. 10, S101-S103
Open AccessUncommon Events of Fall and Mood Changes Observed in Post-COVID-19 Patients: A Case Series
Coronavirus disease 2019 (COVID-19) infection in some patients has been documented to cause acute central nervous system (CNS) affection, or CNS depression, even in the absence of demonstrable hypoxia. These observations indicate that there may be some direct effect of the virus on CNS. In this case series of cured post-COVID-19 cases, mood changes like elation, depression, and emotionally labile state have been reported in three previously healthy individuals. The mood changes are waning very slowly in them with the passage of time. All of them also sustained fall sometime following acute COVID-19. Fall is considered to be an event indicating frailty and old age, and there is no mood change associated with fall in that population. Here, the three cases are being reported because neither fall nor mood changes during post-COVID-19 phase have been reported as yet to the best of our knowledge. The case series is worth reporting to generate awareness about the matter in the scientific community and also to indicate that further research in this field is required either to accept or to reject any correlation between COVID-19 infection and fall or mood change in otherwise healthy individuals, which can even be due to some direct effect of the virus on CNS.
- 23 January 2023
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 102 (6) , e79-e82
Adhesive Capsulitis After COVID-19 Vaccination
Of the many bizarre complications of administration of the COVID 19 vaccine, adhesive capsulitis is almost unheard of, although shoulder injury related to vaccine administration, which by definition has symptom onset within 48 hrs and is caused by faulty injection technique, has been rarely reported. Nine cases of adhesive capsulitis, five males and four females with a mean age of 48.7 ± 12.7 yrs, presenting within 1 mo of intramuscular Covishield vaccine on the ipsilateral deltoid and fulfilling the standard UK FROST Multicenter Study diagnostic criteria are reported. The mean time interval from vaccination until symptom onset was 12.3 ± 3.1 days, and mean symptom duration was 9.4 ± 2.4 wks. Conventional treatment with nonsteroidal anti-inflammatory drugs, followed by intra-articular steroid injection coupled with suprascapular nerve steroid block, improved the pain score and range of movement in 8 wks. The exact pathogenesis remains an enigma, although mechanisms such as local spread via deltoid muscle microvasculature, nerves, or shoulder injury related to vaccine administration causing secondary adhesive capsulitis have been hypothesized. While adhesive capsulitis is a very common diagnosis in the physiatric outpatient setting, the possible association with Covishield vaccination, the Indian version of the Oxford AstraZeneca recombinant ChAdOx1 nCoV-19 vaccine, is almost absent in existing literature and hence likely to be missed by clinicians, which necessitates this report.
- 23 January 2023
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 102 (6) , e79-e82
Adhesive Capsulitis After COVID-19 Vaccination
Of the many bizarre complications of administration of the COVID 19 vaccine, adhesive capsulitis is almost unheard of, although shoulder injury related to vaccine administration, which by definition has symptom onset within 48 hrs and is caused by faulty injection technique, has been rarely reported. Nine cases of adhesive capsulitis, five males and four females with a mean age of 48.7 ± 12.7 yrs, presenting within 1 mo of intramuscular Covishield vaccine on the ipsilateral deltoid and fulfilling the standard UK FROST Multicenter Study diagnostic criteria are reported. The mean time interval from vaccination until symptom onset was 12.3 ± 3.1 days, and mean symptom duration was 9.4 ± 2.4 wks. Conventional treatment with nonsteroidal anti-inflammatory drugs, followed by intra-articular steroid injection coupled with suprascapular nerve steroid block, improved the pain score and range of movement in 8 wks. The exact pathogenesis remains an enigma, although mechanisms such as local spread via deltoid muscle microvasculature, nerves, or shoulder injury related to vaccine administration causing secondary adhesive capsulitis have been hypothesized. While adhesive capsulitis is a very common diagnosis in the physiatric outpatient setting, the possible association with Covishield vaccination, the Indian version of the Oxford AstraZeneca recombinant ChAdOx1 nCoV-19 vaccine, is almost absent in existing literature and hence likely to be missed by clinicians, which necessitates this report.
- Open Access
- 1 January 2023
- Published by University of Szczecin in Central European Journal of Sport Sciences and Medicine
- Vol. 41, 49-60
Pulmonary Function Improves in Persons with Paraplegia after Partial Body Weight Supported Treadmill Training: a Prospective Randomized Study
Wydawnictwo Naukowe Uniwersytetu Szczecińskiego
- 1 January 2023
- Published by University of Szczecin in Central European Journal of Sport Sciences and Medicine
- Vol. 41, 49-60
Open AccessPulmonary Function Improves in Persons with Paraplegia after Partial Body Weight Supported Treadmill Training: a Prospective Randomized Study
Wydawnictwo Naukowe Uniwersytetu Szczecińskiego
- Open Access
- 1 November 2022
- Published by Springer Nature in Cureus
- Vol. 14 (11) , e31009
Factors Associated With Persistence of Dyspnea and Change in Health-Related Quality of Life in Patients With COVID-19 After Discharge
Coronavirus disease 2019 (COVID-19) is a deadly virus affecting multiple organ systems, predominantly the respiratory system. Dyspnea along with the deterioration of health-related quality of life (HRQoL) is common in COVID-19 patients discharged from a dedicated Coronavirus disease (COVID) hospital. Very few studies in India used HRQoL for the assessment of COVID-19 patients after discharge. Our article aims to assess the factors associated with the persistence of dyspnea and HRQoL in discharged patients of COVID-19. A total of 48 patients were included in this prospective observational study. Ethical approval from Institutional Ethics Committee was obtained before the enrolment of patients. Patients having dyspnea at exertion and during discharge were selected for this study. Modified Medical Research Council (mMRC) scale and modified Borg scale were used for assessing dyspnea on activity, and Saint George’s Respiratory Questionnaire (SGRQ) was used to assess HRQoL. Data were collected on the day of discharge (D0) and after 60 days (D60) post-discharge. The significance of changes in parameters from D0 to D60 was evaluated by paired t-test. The mean mMRC, modified Borg, and SGRQ scores at D0 were 2.38±0.98, 3.15±2.12, and 45.36±27.32, respectively, which were improved to 0.94±0.86, 0.94±1.27, and 19.22±18.96 at D60. Age showed significant positive correlations with initial modified Borg (r=0.292, p=0.044) and SGRQ (r=0.332, p=0.021) scores. Body mass index showed significant positive correlations with initial mMRC (r=0.352, p=0.014) and SGRQ (r=0.419, p=0.003) scores. Our study showed that on discharge, many COVID patients have impaired HRQoL. Many of them also have dyspnea on exertion. With the early institution of standard pulmonary rehabilitation protocol, symptoms and HRQoL improves rapidly in a month. Different influencing factors were identified. Long-term follow-up with a bigger sample size is needed to formulate a management strategy for these patients.
- 1 November 2022
- Published by Springer Nature in Cureus
- Vol. 14 (11) , e31009
Open AccessFactors Associated With Persistence of Dyspnea and Change in Health-Related Quality of Life in Patients With COVID-19 After Discharge
Coronavirus disease 2019 (COVID-19) is a deadly virus affecting multiple organ systems, predominantly the respiratory system. Dyspnea along with the deterioration of health-related quality of life (HRQoL) is common in COVID-19 patients discharged from a dedicated Coronavirus disease (COVID) hospital. Very few studies in India used HRQoL for the assessment of COVID-19 patients after discharge. Our article aims to assess the factors associated with the persistence of dyspnea and HRQoL in discharged patients of COVID-19. A total of 48 patients were included in this prospective observational study. Ethical approval from Institutional Ethics Committee was obtained before the enrolment of patients. Patients having dyspnea at exertion and during discharge were selected for this study. Modified Medical Research Council (mMRC) scale and modified Borg scale were used for assessing dyspnea on activity, and Saint George’s Respiratory Questionnaire (SGRQ) was used to assess HRQoL. Data were collected on the day of discharge (D0) and after 60 days (D60) post-discharge. The significance of changes in parameters from D0 to D60 was evaluated by paired t-test. The mean mMRC, modified Borg, and SGRQ scores at D0 were 2.38±0.98, 3.15±2.12, and 45.36±27.32, respectively, which were improved to 0.94±0.86, 0.94±1.27, and 19.22±18.96 at D60. Age showed significant positive correlations with initial modified Borg (r=0.292, p=0.044) and SGRQ (r=0.332, p=0.021) scores. Body mass index showed significant positive correlations with initial mMRC (r=0.352, p=0.014) and SGRQ (r=0.419, p=0.003) scores. Our study showed that on discharge, many COVID patients have impaired HRQoL. Many of them also have dyspnea on exertion. With the early institution of standard pulmonary rehabilitation protocol, symptoms and HRQoL improves rapidly in a month. Different influencing factors were identified. Long-term follow-up with a bigger sample size is needed to formulate a management strategy for these patients.
- 1 October 2014
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 8 (4) , 233-235
Change in tear protein profile in diabetic retinopathy with duration of diabetes
- 1 October 2014
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 8 (4) , 233-235
Change in tear protein profile in diabetic retinopathy with duration of diabetes